-
1
-
-
77952928356
-
Detection of inducible clindamycin resistance in beta-hemolytic streptococci by using the CLSI broth microdilution test and erythromycin- clindamycin combinations
-
Bowling, J. E., et al. 2010. Detection of inducible clindamycin resistance in beta-hemolytic streptococci by using the CLSI broth microdilution test and erythromycin-clindamycin combinations. J. Clin. Microbiol. 48:2275-2277.
-
(2010)
J. Clin. Microbiol.
, vol.48
, pp. 2275-2277
-
-
Bowling, J.E.1
-
2
-
-
72949111486
-
-
Clinical and Laboratory Standards Institute. Approved standard, eighth edition, M07-A8. Clinical and Laboratory Standards Institute, Wayne, PA
-
Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, eighth edition, M07-A8. Clinical and Laboratory Standards Institute, Wayne, PA.
-
(2009)
Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically
-
-
-
3
-
-
33646696219
-
-
Clinical and Laboratory Standards Institute. Twenty-first informational supplement, M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA
-
Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing. Twenty-first informational supplement, M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA.
-
(2011)
Performance Standards for Antimicrobial Susceptibility Testing
-
-
-
4
-
-
10844236221
-
Prevalence and mechanisms of erythromycin resistance in group A and group B Streptococcus: Implications for reporting susceptibility results
-
Desjardins, M., K. L. Delgaty, K. Ramotar, C. Seetaram, and B. Toye. 2004. Prevalence and mechanisms of erythromycin resistance in group A and group B Streptococcus: implications for reporting susceptibility results. J. Clin. Microbiol. 42:5620-5623.
-
(2004)
J. Clin. Microbiol.
, vol.42
, pp. 5620-5623
-
-
Desjardins, M.1
Delgaty, K.L.2
Ramotar, K.3
Seetaram, C.4
Toye, B.5
-
5
-
-
36849054958
-
Prevalence and mechanisms of erythromycin and clindamycin resistance in clinical isolates of beta-hemolytic streptococci of Lancefield groups A, B, C, and G in Seville, Spain
-
Diaz, M., M. J. Torres Sanchez, and M. J. Aznar. 2008. Prevalence and mechanisms of erythromycin and clindamycin resistance in clinical isolates of beta-hemolytic streptococci of Lancefield groups A, B, C, and G in Seville, Spain. Clin. Microbiol. Infect. 14:85-87.
-
(2008)
Clin. Microbiol. Infect.
, vol.14
, pp. 85-87
-
-
Diaz, M.1
Torres Sanchez, M.J.2
Aznar, M.J.3
-
6
-
-
0037083024
-
Mechanisms of resistance to macrolides and lincosamides: Nature of the resistance elements and their clinical implications
-
Leclercq, R. 2002. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin. Infect. Dis. 34:482-492.
-
(2002)
Clin. Infect. Dis.
, vol.34
, pp. 482-492
-
-
Leclercq, R.1
-
7
-
-
12144267967
-
Inducible clindamycin resistance in staphylococci: Should clinicians and microbiologists be concerned?
-
Lewis, J. S., II, and J. H. Jorgensen. 2005. Inducible clindamycin resistance in staphylococci: should clinicians and microbiologists be concerned? Clin. Infect. Dis. 40:280-285.
-
(2005)
Clin. Infect. Dis.
, vol.40
, pp. 280-285
-
-
Lewis II, J.S.1
Jorgensen, J.H.2
-
8
-
-
67349233039
-
Macrolide resistance in Streptococcus pyogenes: Prevalence, resistance determinants, and emm types
-
Michos, A. G., et al. 2009. Macrolide resistance in Streptococcus pyogenes: prevalence, resistance determinants, and emm types. Diagn. Microbiol. Infect. Dis. 64:295-299.
-
(2009)
Diagn. Microbiol. Infect. Dis.
, vol.64
, pp. 295-299
-
-
Michos, A.G.1
-
9
-
-
33745249533
-
Investigation of inducible clindamycin and telithromycin resistance in isolates of beta-hemolytic streptococci
-
Raney, P. M., F. C. Tenover, R. B. Carey, J. E. McGowan, Jr., and J. B. Patel. 2006. Investigation of inducible clindamycin and telithromycin resistance in isolates of beta-hemolytic streptococci. Diagn. Microbiol. Infect. Dis. 55: 213-218.
-
(2006)
Diagn. Microbiol. Infect. Dis.
, vol.55
, pp. 213-218
-
-
Raney, P.M.1
Tenover, F.C.2
Carey, R.B.3
McGowan Jr., J.E.4
Patel, J.B.5
-
10
-
-
23844555181
-
Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003
-
Richter, S. S., et al. 2005. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003. Clin. Infect. Dis. 41:599-608.
-
(2005)
Clin. Infect. Dis.
, vol.41
, pp. 599-608
-
-
Richter, S.S.1
-
11
-
-
53649088204
-
Streptococcus
-
P. R. Murray, E. J. Baron, J. H. Jorgensen, M. A. Pfaller, and R. H. Yolken (ed.), 9th ed. American Society for Microbiology, Washington, DC
-
Spellerberg, B., and C. Brandt. 2007. Streptococcus, p. 412-429. In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. A. Pfaller, and R. H. Yolken (ed.), Manual of clinical microbiology, 9th ed. American Society for Microbiology, Washington, DC.
-
(2007)
Manual of Clinical Microbiology
, pp. 412-429
-
-
Spellerberg, B.1
Brandt, C.2
-
12
-
-
78649605964
-
Prevention of perinatal group B streptococcal disease; revised guidelines from CDC, 2010
-
Verani, J. R., et al. 2010. Prevention of perinatal group B streptococcal disease; revised guidelines from CDC, 2010. MMWR Recomm. Rep. 59(RR-10):1-36.
-
(2010)
MMWR Recomm. Rep.
, vol.59
, Issue.RR-10
, pp. 1-36
-
-
Verani, J.R.1
|